Tailoring Treatment to the Individual Patient - Will Inflammatory Bowel Disease Medicine Be Personalized?

Publisher： Karger

E-ISSN： 1421-9875|33|1|82-89

ISSN： 0257-2753

Source： Digestive Diseases, Vol.33, Iss.1, 2015-09, pp. : 82-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailoring Treatment to the Individual Patient: Drug Monitoring

By  

Digestive Diseases, Vol. 32, Iss. 1, 2014-12 ,pp. : 88-91

Karger

Access to resources Recommend Favorite

Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

By Bendtzen Klaus   Ainsworth Mark   Steenholdt Casper   Thomsen Ole Østergaard   Brynskov Jørn  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 774-781

Informa Healthcare

Access to resources Recommend Favorite

Perspectives for Regenerative Medicine in the Treatment of Inflammatory Bowel Diseases

By  

Digestion, Vol. 92, Iss. 2, 2015-07 ,pp. : 73-77

Karger

Access to resources Recommend Favorite

Patient’s Perspectives Important for Early Anti-Tumor Necrosis Factor Treatment in Inflammatory Bowel Disease

By  

Digestion, Vol. 79, Iss. 1, 2009-02 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

Patients’ Preferences regarding Shared Decision-Making in the Treatment of Inflammatory Bowel Disease: Results from a Patient-Empowerment Study

By  

Digestion, Vol. 81, Iss. 2, 2010-01 ,pp. : 113-119

Karger

Access to resources Recommend Favorite